1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015" provides data on the Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 5
Introduction 6
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) 20
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Reata Pharmaceuticals, Inc. 27
Clinical Trial Overview of Reata Pharmaceuticals, Inc. 27
SkyePharma PLC 28
Clinical Trial Overview of SkyePharma PLC 28
Mundipharma International Limited 29
Clinical Trial Overview of Mundipharma International Limited 29
Clinical Trial Overview of Top Institutes / Government 30
University of Texas M. D. Anderson Cancer Center 30
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 30
Memorial Sloan Kettering Cancer Center 31
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 31
National Cancer Institute 32
Clinical Trial Overview of National Cancer Institute 32
Duke University 33
Clinical Trial Overview of Duke University 33
Northwestern University 34
Clinical Trial Overview of Northwestern University 34
Baylor College of Medicine 35
Clinical Trial Overview of Baylor College of Medicine 35
University Hospital, Bonn 36
Clinical Trial Overview of University Hospital, Bonn 36
National Cancer Center 37
Clinical Trial Overview of National Cancer Center 37
National Taiwan University Hospital 38
Clinical Trial Overview of National Taiwan University Hospital 38
University of Washington 39
Clinical Trial Overview of University of Washington 39
Five Key Clinical Profiles 40
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 69

List of Tables
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 20
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Reata Pharmaceuticals, Inc., 2015* 27
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by SkyePharma PLC, 2015* 28
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2015* 29
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 30
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 31
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 32
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 33
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 34
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 35
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bonn, 2015* 36
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015* 37
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 38
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 39

List of Figures
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 67

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Pathology Statistics in Zambia

  • December 2016
    13 pages
  • Pathology  

  • Zambia  

View report >

Infectious Disease Statistics in the US

  • December 2016
    32 pages
  • Infectious Dise...  

    Asthma  

  • United States  

View report >

Infectious Disease Statistics in Africa

  • December 2016
    3 pages
  • Infectious Dise...  

    Therapy  

    Pharmaceutical  

  • Africa  

    World  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.